UBS Group’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.21M | Buy |
|
|||||
|
2025
Q2 | $1.42M | Buy |
|
|||||
|
2025
Q1 | $1.2M | Buy |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $142K | Sell |
|
|||||
|
2024
Q2 | $463K | Sell |
|
|||||
|
2024
Q1 | $971K | Buy |
|
|||||
|
2023
Q4 | $276K | Buy |
|
|||||
|
2023
Q3 | $110K | Sell |
|
|||||
|
2023
Q2 | $296K | Buy |
|
|||||
|
2023
Q1 | $39K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $16K | Buy |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $31K | Sell |
|
|||||
|
2021
Q4 | $18K | Sell |
|
|||||
|
2021
Q3 | $496K | Buy |
|
|||||
|
2021
Q2 | $603K | Buy |
|
|||||
|
2021
Q1 | $672K | Buy |
|
|||||
|
2020
Q4 | $221K | Buy |
|
|||||
|
2020
Q3 | $18K | Sell |
|
|||||
|
2020
Q2 | $69K | Buy |
|
|||||
|
2020
Q1 | $11K | Sell |
|
|||||
|
2019
Q4 | $145K | Sell |
|
|||||
|
2019
Q3 | $1.66M | Buy |
|
|||||
|
2019
Q2 | $640K | Buy |
|
|||||
|
2019
Q1 | $71K | Buy |
|
|||||
|
2018
Q4 | $19K | Buy |
|
|||||
|
2018
Q3 | $6K | Sell |
|
|||||
|
2018
Q2 | $10K | Sell |
|
|||||
|
2018
Q1 | $684K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $16K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $10K | Sell |
|
|||||
|
2016
Q4 | $38K | Buy |
|
|||||
|
2016
Q3 | $15K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $12K | Buy |
|
|||||
|
2015
Q4 | $30K | Buy |
|